Tiziana Life Sciences Ltd Share Price (TLSA.US)

ACUT 1 5 †

Accustem Sciences Inc USD0.001 $0.16 -$0.12 -42.92%

Bad day yesterday for ACUT

Thanks for posting the link. This latest phase 2 trial appears comprehensive and detailed, such that I would say when results are known at the end of 2026 we will finally know if foralumab really is the business. I think all LTHs now want a yes or no result and no more perhaps. So a move next year to phase 3 and a farm in/out with a major pharma has to be the goal.

Https://ir.tizianalifesciences.com/news-releases/news-release-details/tiziana-announces-last-patient-successfully-dosed-its-phase-2

'if someone owns 34% of a public company on nasdaq what can they do?' (question to Google AI)

Owning 34% of a public company on Nasdaq gives a single investor de facto "negative control" over the company. They can effectively block major corporate actions (such as mergers, acquisitions, or charter amendments), influence board decisions, and potentially trigger hostile takeovers or buyout negotiations.

A 34% shareholder can execute several specific actions:

1. Influence or Block Corporate Decisions

Block Special Resolutions: In corporate law, major actions like amending the articles of incorporation, authorizing stock buybacks, or executing a merger usually require a supermajority vote (often 66.6% or 75%). A 34% stake easily blocks these. [1, 2]

Push for Board Representation: With over a third of the voting power, this investor can demand seats on the Board of Directors. They can either appoint themselves or nominate representatives to directly influence management.

Veto Board Actions: If the company's bylaws require a supermajority of the board or shareholders for specific moves, this shareholder can act as a permanent check against the rest of the board.

2. Initiate or Force a Buyout

Launch a Tender Offer: The investor can attempt to acquire the rest of the outstanding shares directly from the public to take the company private. [1, 2]

Force a Sale: If the investor is an activist or a competitor, their large stake can compel the board to seek a buyer or merge with a larger company to maximize value. [1, 2]

Block a Sale: If another entity attempts to acquire the company, this investor can either block the sale outright or demand to negotiate a premium for their massive block. [1]

3. Trigger Regulatory and Exchange Rules

SEC Disclosures: The SEC requires any investor acquiring more than 5% of a public company's stock to file detailed reports (like Schedule 13D for activist control or Schedule 13G for passive investors). Crossing 34% requires continuous and transparent updates on intentions. [1, 2, 3, 4, 5]

Nasdaq "Change of Control": Nasdaq rules treat any large stock issuance that impacts control (often crossing 20%) very strictly. While 34% is already high, any new acquisition or dilution by the company might trigger shareholder approval requirements on Nasdaq. [1, 2]

4. Monetize the Stake

Block or Access Secondary Offerings: If the company needs to raise capital by issuing new shares, the shareholder can leverage their position or vote to protect their equity from dilution.

Liquidate or Hedge: The investor can sell shares in the open market, or leverage the stock by borrowing against its value, as long as it does not violate SEC insider trading law

15th June 2026 - Executive Chairman and Founder, Mr. Gabriele Cerrone, through Panetta Partners Ltd, an entity in which he has a beneficial interest, has increased his holdings with the purchase of 15,000 common shares at $1.11 per share, bringing his total holding to 44,772,230 common shares, which is 34.89% of issued share capital.